256
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Severe Hypercalcemia as an Initial Presentation of Advanced Hepatocellular Carcinoma: A Case Report

ORCID Icon, , & ORCID Icon
Pages 1577-1580 | Published online: 28 Apr 2022

References

  • Newman NB, Jabbour SK, Hon JDC, et al. Hepatocellular carcinoma without cirrhosis presenting with hypercalcemia: case report and literature review. J Clin Exp Hepatol. 2015;5(2):163–166. doi:10.1016/j.jceh.2015.04.001
  • Baş Y, Hassan HA, Adıgüzel C, Bulur O, Ibrahim İA, Soydan S. The distribution of cancer cases in Somalia. Semin Oncol. 2017;44(3):178–186. doi:10.1053/j.seminoncol.2017.10.007
  • Şahiner F, Tanoğlu A, Hoşbul T, et al. Seroprevalence and genotype distribution of hepatitis c virus in Mogadishu, Somalia: a comprehensive study. J Mol Virol Immunol. 2021;2(3):115–122. doi:10.46683/jmvi.2021.38
  • El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;265(12):1118–1127. doi:10.1056/NEJMra1001683
  • Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36(6):1349–1354. doi:10.1002/hep.1840360609
  • Gaddikeri S, McNeeley MF, Wang CL, et al. Hepatocellular carcinoma in the noncirrhotic liver. Am J Roentgenol. 2014;203(1):34–47. doi:10.2214/AJR.13.11511
  • Das L, Viji M, Mahalakshmi honasoge ES. Hepatocellular carcinoma presenting as hypercalcemia. Endocr Pract. 2018;24:139–140.
  • Sorlini M, Benini F, Cravarezza P, Romanelli G. Hypoglycemia, an atypical early sign of hepatocellular carcinoma. J Gastrointest Cancer. 2010;41(3):209–211. doi:10.1007/s12029-010-9137-0
  • Hinterhuber G, Drach J, Riedl E, et al. Paraneoplastic pemphigus in association with hepatocellular carcinoma. J Am Acad Dermatol. 2003;49(3):538–540. doi:10.1067/S0190-9622(03)01581-0
  • Hwang SJ, Luo JC, Li CP, et al. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10(17):2472–2477. doi:10.3748/wjg.v10.i17.2472
  • Chang PE, Ong WC, Lui HF, Tan CK. Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma. ISRN Oncol. 2013;2013:1–8. doi:10.1155/2013/684026
  • Giannini EG, Marenco S, Bruzzone L, et al. Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis. 2013;45(2):164–169. doi:10.1016/j.dld.2012.08.018
  • Cillo U, Vitale A, Grigoletto F, et al. Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol. 2006;44(4):723–731. doi:10.1016/j.jhep.2005.12.015
  • Stewart AF. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373–379. doi:10.1056/NEJMcp042806
  • Stroffolini T, Andreone P, Andriulli A, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol. 1998;29(6):944–952. doi:10.1016/S0168-8278(98)80122-0
  • Shane E, Berenson JR. Treatment of hypercalcemia; 2022.